← Leaderboards
Paola Grandi
University Of Pittsburgh At Pittsburgh
$940,989
Attributed
$940,989
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $316K · FY2014–16$500K$375K$250K$125K$0
'14
'15
'16
Funding mix
By agency
NIH$940,989 · 1
By mechanism
R01$940,989 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joseph C. Glorioso$19,383,290
- David J. Fink$11,160,913
- William F. Goins$3,333,127
- Paul R. Kinchington$19,833,198
- Robert L Hendricks$15,975,328
Others in their field
Top investigators on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$467,028,615
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$263,149,639
- Constance Ann Benson · University Of California, San Diego$228,304,380
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
Effective TherapyEfficacy TestingBaseAlternative TreatmentAttenuationBrainBrain CellBrain NeoplasmsCell GrowthAttenuatedCell MotilityCellsCell SurfaceCharacteristicsClassificationClinical TrialsComplementCspg4 GeneCytoskeletonDesignDetectionCell KillingEffectivenessEngineering
Grant awards (3)
Enhanced GBM Therapy Using a New Class of HSV Oncolytic Vector$316,018
R01 · FY2016 · CA · contact PI
Enhanced GBM Therapy Using a New Class of HSV Oncolytic Vector$316,018
R01 · FY2015 · CA · contact PI
Enhanced GBM Therapy Using a New Class of HSV Oncolytic Vector$308,953
R01 · FY2014 · CA · contact PI